# Harte Hanks Inc: overview HHS · Nasdaq · CIK 45919 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/hhs.md) · [Financials](/companies/hhs/financials.md) · [Filings](/companies/hhs/filings.md) · [Insiders](/companies/hhs/insiders.md) Latest reported revenue: [$38.0m](/filings/0000045919-26-000005.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000045919-26-000005). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [47.6](/filings/0001628280-25-051383.md) | [47.1 d](/filings/0001628280-26-018894.md) | [41.6](/filings/0001628280-26-035323.md) | [38.6](/filings/0000045919-26-000005.md) | [39.5](/filings/0001628280-25-051383.md) | [39.9 d](/filings/0001628280-26-018894.md) | [37.3](/filings/0001628280-26-035323.md) | [38.0](/filings/0000045919-26-000005.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [4.0%](/filings/0001628280-25-051383.md) | [(3.3%) d](/filings/0001628280-26-018894.md) | [(0.1%)](/filings/0001628280-26-035323.md) | [0.1%](/filings/0000045919-26-000005.md) | [1.3%](/filings/0001628280-25-051383.md) | [(0.3%) d](/filings/0001628280-26-018894.md) | [(2.1%)](/filings/0001628280-26-035323.md) | [(11.8%)](/filings/0000045919-26-000005.md) | | Net margin | % | [0.3%](/filings/0001628280-25-051383.md) | [(5.2%) d](/filings/0001628280-26-018894.md) | [(0.9%)](/filings/0000045919-26-000005.md) | [(0.9%)](/filings/0000045919-26-000005.md) | [(5.8%)](/filings/0001628280-25-051383.md) | [5.5% d](/filings/0001628280-26-018894.md) | [(1.7%)](/filings/0000045919-26-000005.md) | [(13.2%)](/filings/0000045919-26-000005.md) | | Diluted EPS | $ per share | [0.02](/filings/0001628280-25-051383.md) | not reported | [(0.05)](/filings/0001628280-26-035323.md) | [(0.05)](/filings/0000045919-26-000005.md) | [(0.31)](/filings/0001628280-25-051383.md) | not reported | [(0.08)](/filings/0001628280-26-035323.md) | [(0.67)](/filings/0000045919-26-000005.md) | | Free cash flow | $m | [(4.9) d](/filings/0001628280-25-051383.md) | [3.4 d](/filings/0001628280-26-018894.md) | [(0.9)](/filings/0001628280-26-035323.md) | [(5.1) d](/filings/0000045919-26-000005.md) | [2.2 d](/filings/0001628280-25-051383.md) | [(0.7) d](/filings/0001628280-26-018894.md) | [(0.9)](/filings/0001628280-26-035323.md) | [(2.1) d](/filings/0000045919-26-000005.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [195](/filings/0001437749-23-008877.md) | [206](/filings/0000045919-24-000014.md) | [191](/filings/0000045919-25-000008.md) | [185](/filings/0001628280-26-018894.md) | [160](/filings/0001628280-26-018894.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [3.9%](/filings/0001437749-23-008877.md) | [7.3%](/filings/0000045919-24-000014.md) | [1.8%](/filings/0000045919-25-000008.md) | [1.1%](/filings/0001628280-26-018894.md) | [0.2%](/filings/0001628280-26-018894.md) | | Net margin | % | [7.7%](/filings/0001437749-23-008877.md) | [17.8%](/filings/0000045919-24-000014.md) | [(0.8%)](/filings/0000045919-25-000008.md) | [(16.4%)](/filings/0001628280-26-018894.md) | [(0.5%)](/filings/0001628280-26-018894.md) | | Diluted EPS | $ per share | [1.76](/filings/0001437749-23-008877.md) | [4.75](/filings/0000045919-24-000014.md) | [(0.21)](/filings/0000045919-25-000008.md) | [(4.15)](/filings/0001628280-26-018894.md) | [(0.11)](/filings/0001628280-26-018894.md) | | Free cash flow | $m | [(4.8)](/filings/0001437749-23-008877.md) | [23.0](/filings/0000045919-24-000014.md) | [7.7](/filings/0000045919-25-000008.md) | [(6.7)](/filings/0001628280-26-018894.md) | [(4.5)](/filings/0001628280-26-018894.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hhs/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BLAIR WILLIAM & CO/IL](/funds/902367.md) | 2026-06-30 | $1.4m | 660,845 | | Unchanged | | [WESTERLY CAPITAL MANAGEMENT, LLC](/funds/1546172.md) | 2026-06-30 | $1.4m | 635,000 | | Added +8,000 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $559.5k | 259,036 | | Unchanged | | [Krilogy Financial LLC](/funds/1659047.md) | 2026-06-30 | $329.1k | 152,379 | | Added +34,204 | | [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $189.6k | 87,757 | | Unchanged | | [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $189.6k | 87,757 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $118.8k | 54,988 | | Reduced −2,889 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $92.1k | 42,621 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $66.1k | 30,619 | | Unchanged | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $57.2k | 26,497 | | Unchanged | ## Recent filings [All 1,030 filings](/companies/hhs/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-15 | 16:04 ET | [8-K](/filings/0001628280-26-062044.md) | 8.01 Other events | 0001628280-26-062044 | | 2026-08-24 | 15:43 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002295.md) | Ownership report, active investor, amended | 0000921895-26-002295 | | 2026-08-19 | 16:17 ET | [8-K](/filings/0000045919-26-000009.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000045919-26-000009 | | 2026-08-14 | 17:08 ET | [10-Q](/filings/0000045919-26-000005.md) | Quarterly report, period 2026-06-30 | 0000045919-26-000005 | | 2026-05-21 | 16:35 ET | [8-K](/filings/0001628280-26-037327.md) | 5.07 Shareholder vote results | 0001628280-26-037327 | | 2026-05-15 | 08:16 ET | [10-Q](/filings/0001628280-26-035323.md) | Quarterly report, period 2026-03-31 | 0001628280-26-035323 | | 2026-05-14 | 16:24 ET | [8-K](/filings/0001628280-26-035139.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-035139 | | 2026-04-09 | 17:05 ET | [DEF 14A](/filings/0001628280-26-024524.md) | Proxy statement, period 2026-04-09 | 0001628280-26-024524 | | 2026-03-18 | 18:29 ET | [8-K](/filings/0001628280-26-018959.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-018959 | | 2026-03-17 | 17:20 ET | [10-K](/filings/0001628280-26-018894.md) | Annual report, period 2025-12-31 | 0001628280-26-018894 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-018894.md), filed Mar 17, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/65bf3afd-27ad-4a90-9b16-003c8e858eb2) ## About the filer - CIK: 45919 - Tickers: HHS - Exchange: Nasdaq - SIC code: 7331 Services-Direct Mail Advertising Services - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.